COST ANALYSIS OF RALTEGRAVIR VERSUS ATAZANAVIR/R OR DARUNAVIR/R FOR TREATMENT-NAIVE ADULTS WITH HIV-1 INFECTION IN THE UNITED STATES
May 1, 2016, 00:00 AM
10.1016/j.jval.2016.03.1207
https://www.valueinhealthjournal.com/article/S1098-3015(16)01275-4/fulltext
Section Title :
Infection - Cost Studies
Section Order :
706
First Page :
A214
https://www.valueinhealthjournal.com/action/showCitFormats?pii=S1098-3015(16)01275-4&doi=10.1016/j.jval.2016.03.1207